Articles - 1vdv mentioned but not cited (2)
- Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones. Smelcerovic Z, Veljkovic A, Kocic G, Yancheva D, Petronijevic Z, Anderluh M, Smelcerovic A. Chem Biol Interact 229 73-81 (2015)
- Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor. Vitale RM, Antenucci L, Gavagnin M, Raimo G, Amodeo P. J Enzyme Inhib Med Chem 32 345-354 (2017)
Reviews citing this publication (12)
- Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pacher P, Nivorozhkin A, Szabó C. Pharmacol Rev 58 87-114 (2006)
- The mononuclear molybdenum enzymes. Hille R, Hall J, Basu P. Chem Rev 114 3963-4038 (2014)
- Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. Nishino T, Okamoto K, Eger BT, Pai EF, Nishino T. FEBS J 275 3278-3289 (2008)
- Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies. Li W, Yang S. Brain Circ 2 153-163 (2016)
- MicroRNAs in pulmonary arterial remodeling. Grant JS, White K, MacLean MR, Baker AH. Cell Mol Life Sci 70 4479-4494 (2013)
- Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout. Nishino T, Okamoto K. J Biol Inorg Chem 20 195-207 (2015)
- Xanthine oxidase inhibitors: a patent survey. Kumar R, Darpan, Sharma S, Singh R. Expert Opin Ther Pat 21 1071-1108 (2011)
- Electronic structure contributions to reactivity in xanthine oxidase family enzymes. Stein BW, Kirk ML. J Biol Inorg Chem 20 183-194 (2015)
- Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure-Based Drug Design. Luna G, Dolzhenko AV, Mancera RL. ChemMedChem 14 714-743 (2019)
- Tumor lysis syndrome in childhood malignancies. Cheung WL, Hon KL, Fung CM, Leung AK. Drugs Context 9 (2020)
- Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase. Sekine M, Okamoto K, Ichida K. Biomedicines 9 1723 (2021)
- XDH and XO Research and Drug Discovery-Personal History. Nishino T. Molecules 28 4440 (2023)
Articles citing this publication (43)
- Molybdenum enzymes in higher organisms. Hille R, Nishino T, Bittner F. Coord Chem Rev 255 1179-1205 (2011)
- FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase. Matsumoto K, Okamoto K, Ashizawa N, Nishino T. J Pharmacol Exp Ther 336 95-103 (2011)
- Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Tanaka T, Doi K, Maeda-Mamiya R, Negishi K, Portilla D, Sugaya T, Fujita T, Noiri E. Am J Pathol 174 1203-1211 (2009)
- Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol. Okamoto K, Eger BT, Nishino T, Pai EF, Nishino T. Nucleosides Nucleotides Nucleic Acids 27 888-893 (2008)
- Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. Fini MA, Orchard-Webb D, Kosmider B, Amon JD, Kelland R, Shibao G, Wright RM. J Cell Biochem 105 1008-1026 (2008)
- Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity. Perez-Ruiz F, Hernando I, Villar I, Nolla JM. J Clin Rheumatol 11 129-133 (2005)
- Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. Gibbings S, Elkins ND, Fitzgerald H, Tiao J, Weyman ME, Shibao G, Fini MA, Wright RM. J Biol Chem 286 961-975 (2011)
- Structure-activity relationship of C6-C3 phenylpropanoids on xanthine oxidase-inhibiting and free radical-scavenging activities. Chang YC, Lee FW, Chen CS, Huang ST, Tsai SH, Huang SH, Lin CM. Free Radic Biol Med 43 1541-1551 (2007)
- Chemical Evidence for Potent Xanthine Oxidase Inhibitory Activity of Ethyl Acetate Extract of Citrus aurantium L. Dried Immature Fruits. Liu K, Wang W, Guo BH, Gao H, Liu Y, Liu XH, Yao HL, Cheng K. Molecules 21 302 (2016)
- Ultrahigh performance liquid chromatography-triple quadrupole mass spectrometry inhibitors fishing assay: a novel method for simultaneously screening of xanthine oxidase inhibitor and superoxide anion scavenger in a single analysis. Liu S, Xing J, Zheng Z, Song F, Liu Z, Liu S. Anal Chim Acta 715 64-70 (2012)
- Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis. Cassidy CE, Setzer WN. J Mol Model 16 311-326 (2010)
- Crystal structures of mammalian xanthine oxidoreductase bound with various inhibitors: allopurinol, febuxostat, and FYX-051. Okamoto K, Nishino T. J Nippon Med Sch 75 2-3 (2008)
- Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia. Khanna S, Burudkar S, Bajaj K, Shah P, Keche A, Ghosh U, Desai A, Srivastava A, Kulkarni-Almeida A, Deshmukh NJ, Dixit A, Brahma MK, Bahirat U, Doshi L, Nemmani KV, Tannu P, Damre A, B-Rao C, Sharma R, Sivaramakrishnan H. Bioorg Med Chem Lett 22 7543-7546 (2012)
- Discovery of xanthine oxidase inhibitors and/or α-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of apigenin. Su ZR, Fan SY, Shi WG, Zhong BH. Bioorg Med Chem Lett 25 2778-2781 (2015)
- Inhibition of xanthine oxidase by thiosemicarbazones, hydrazones and dithiocarbazates derived from hydroxy-substituted benzaldehydes. Leigh M, Raines DJ, Castillo CE, Duhme-Klair AK. ChemMedChem 6 1107-1118 (2011)
- Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol. Kalra S, Jena G, Tikoo K, Mukhopadhyay AK. BMC Biochem 8 8 (2007)
- Discovery of novel xanthone derivatives as xanthine oxidase inhibitors. Hu L, Hu H, Wu W, Chai X, Luo J, Wu Q. Bioorg Med Chem Lett 21 4013-4015 (2011)
- Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits. B-Rao C, Kulkarni-Almeida A, Katkar KV, Khanna S, Ghosh U, Keche A, Shah P, Srivastava A, Korde V, Nemmani KV, Deshmukh NJ, Dixit A, Brahma MK, Bahirat U, Doshi L, Sharma R, Sivaramakrishnan H. Bioorg Med Chem 20 2930-2939 (2012)
- In vitro effect of novel β-lactam compounds on xanthine oxidase enzyme activity. Bytyqi-Damoni A, Genç H, Zengin M, Beyaztas S, Gençer N, Arslan O. Artif Cells Blood Substit Immobil Biotechnol 40 369-377 (2012)
- Potential xanthine oxidase inhibitory activity of endophytic Lasiodiplodia pseudotheobromae. Kapoor N, Saxena S. Appl Biochem Biotechnol 173 1360-1374 (2014)
- Screening and determination of potential xanthine oxidase inhibitors from Radix Salviae Miltiorrhizae using ultrafiltration liquid chromatography-mass spectrometry. Liu Y, Liu S, Liu Z. J Chromatogr B Analyt Technol Biomed Life Sci 923-924 48-53 (2013)
- Effects of Toona sinensis Leaf Extract and Its Chemical Constituents on Xanthine Oxidase Activity and Serum Uric Acid Levels in Potassium Oxonate-Induced Hyperuricemic Rats. Yuk HJ, Lee YS, Ryu HW, Kim SH, Kim DS. Molecules 23 E3254 (2018)
- New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway. Kato S, Kato M, Kusano T, Nishino T. J Neuropathol Exp Neurol 75 1124-1144 (2016)
- Antihyperuricemic effects of thiadiazolopyrimidin-5-one analogues in oxonate treated rats. Sathisha KR, Gopal S, Rangappa KS. Eur J Pharmacol 776 99-105 (2016)
- DKB114, A Mixture of Chrysanthemum Indicum Linne Flower and Cinnamomum Cassia (L.) J. Presl Bark Extracts, Improves Hyperuricemia through Inhibition of Xanthine Oxidase Activity and Increasing Urine Excretion. Lee YS, Kim SH, Yuk HJ, Kim DS. Nutrients 10 E1381 (2018)
- Phloroglucinol Derivatives from Dryopteris crassirhizoma as Potent Xanthine Oxidase Inhibitors. Yuk HJ, Kim JY, Sung YY, Kim DS. Molecules 26 E122 (2020)
- Synergistic Uric Acid-Lowering Effects of the Combination of Chrysanthemum indicum Linne Flower and Cinnamomum cassia (L.) J. Persl Bark Extracts. Lee YS, Son E, Kim SH, Lee YM, Kim OS, Kim DS. Evid Based Complement Alternat Med 2017 9764843 (2017)
- Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor. Kaur M, Kaur A, Mankotia S, Singh H, Singh A, Singh JV, Gupta MK, Sharma S, Nepali K, Bedi PMS. Eur J Med Chem 131 14-28 (2017)
- Tetragonia tetragonoides (Pall.) Kuntze (New Zealand Spinach) Prevents Obesity and Hyperuricemia in High-Fat Diet-Induced Obese Mice. Lee YS, Kim SH, Yuk HJ, Lee GJ, Kim DS. Nutrients 10 E1087 (2018)
- Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors. Peng J, Li Y, Zhou Y, Zhang L, Liu X, Zuo Z. J Recept Signal Transduct Res 38 246-255 (2018)
- Structure-Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase. Zhou LY, Peng JL, Wang JM, Geng YY, Zuo ZL, Hua Y. Molecules 23 E365 (2018)
- Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors. Zhang TJ, Wu QX, Li SY, Wang L, Sun Q, Zhang Y, Meng FH, Gao H. Bioorg Med Chem Lett 27 3812-3816 (2017)
- Synthesis, activity testing and molybdenum(VI) complexation of Schiff bases derived from 2,4,6-trihydroxybenzaldehyde investigated as xanthine oxidase inhibitors. Leigh M, Castillo CE, Raines DJ, Duhme-Klair AK. ChemMedChem 6 612-616 (2011)
- Association of serum uric acid with the risk of developing hypertension: A prospective cohort study with mediation analysis. Dong J, Hu LK, Lu YK, Liu YH, Chu X, Yan YX. Hypertens Res 46 345-356 (2023)
- Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700. Sai Y, Kato Y, Nakamura K, Kato S, Nishimura T, Kubo Y, Tamai I, Yang S, Hu Z, Yamada I, Tsuji A. J Pharm Sci 95 336-347 (2006)
- Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia. Sugioka N, Takai M, Yoshida K, Yasuda K, Fukushima K, Kokuhu T, Okamoto M, Yoshimura N, Takada K. J Clin Pharm Ther 35 323-332 (2010)
- Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors. Nishiwaki K, Ohigashi K, Deguchi T, Murata K, Nakamura S, Matsuda H, Nakanishi I. Chem Pharm Bull (Tokyo) 66 741-747 (2018)
- Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat. Maghsoud Y, Dong C, Cisneros GA. ACS Catal 13 6023-6043 (2023)
- Potent Xanthine Oxidase Inhibitory Activity of Constituents of Agastache rugosa (Fisch. and C.A.Mey.) Kuntze. Yuk HJ, Ryu HW, Kim DS. Foods 12 573 (2023)
- The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment. Kumrungsee T, Kariya T, Hashimoto K, Koyano T, Yazawa N, Hashimoto T, Sanada Y, Matsuyama M, Sotomaru Y, Sakurai H, van de Loo FAJ, Yanaka N. Sci Rep 9 14101 (2019)
- Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase. Sekine M, Okamoto K, Pai EF, Nagata K, Ichida K, Hille R, Nishino T. J Biol Chem 299 105189 (2023)
- Identification of xanthine oxidase inhibitors through hierarchical virtual screening. Yang Y, Zhang L, Tian J, Ye F, Xiao Z. RSC Adv 10 27752-27763 (2020)
- Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study. Maghsoud Y, Dong C, Cisneros GA. J Chem Inf Model 63 4190-4206 (2023)